Alpa Laboratories Limited
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.
Alpa Laboratories Limited (ALPA) - Total Liabilities
Latest total liabilities as of September 2025: ₹543.14 Million INR
Based on the latest financial reports, Alpa Laboratories Limited (ALPA) has total liabilities worth ₹543.14 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alpa Laboratories Limited - Total Liabilities Trend (2002–2025)
This chart illustrates how Alpa Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alpa Laboratories Limited Competitors by Total Liabilities
The table below lists competitors of Alpa Laboratories Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Magnum Ventures Limited
NSE:MAGNUM
|
India | ₹5.24 Billion |
|
Binah Capital Group, Inc. Common Stock
NASDAQ:BCG
|
USA | $49.47 Million |
|
Mason Graphite Inc.
OTCQB:MGPHF
|
USA | $149.56K |
|
Baltic Sea Properties AS
OL:BALT
|
Norway | Nkr881.60 Million |
|
Hawthorn Resources Ltd
AU:HAW
|
Australia | AU$1.56 Million |
|
Power Line Engineering Public Company Limited
BK:PLE
|
Thailand | ฿12.43 Billion |
|
Stock Trend Capital Inc.
PINK:STOCF
|
USA | $137.48K |
Liability Composition Analysis (2002–2025)
This chart breaks down Alpa Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpa Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpa Laboratories Limited (2002–2025)
The table below shows the annual total liabilities of Alpa Laboratories Limited from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹511.59 Million | +67.94% |
| 2024-03-31 | ₹304.62 Million | -7.34% |
| 2023-03-31 | ₹328.75 Million | -1.89% |
| 2022-03-31 | ₹335.08 Million | +2.39% |
| 2021-03-31 | ₹327.27 Million | +56.00% |
| 2020-03-31 | ₹209.79 Million | -7.68% |
| 2019-03-31 | ₹227.24 Million | -5.22% |
| 2018-03-31 | ₹239.75 Million | -22.16% |
| 2017-03-31 | ₹308.00 Million | -39.48% |
| 2016-03-31 | ₹508.91 Million | +21.90% |
| 2015-03-31 | ₹417.49 Million | +8.71% |
| 2014-03-31 | ₹384.04 Million | +23.47% |
| 2013-03-31 | ₹311.05 Million | -3.34% |
| 2012-03-31 | ₹321.79 Million | -0.02% |
| 2011-03-31 | ₹321.86 Million | -26.77% |
| 2010-03-31 | ₹439.52 Million | -30.32% |
| 2009-03-31 | ₹630.80 Million | +15.74% |
| 2008-03-31 | ₹545.03 Million | +61.61% |
| 2007-03-31 | ₹337.25 Million | -5.00% |
| 2006-03-31 | ₹355.00 Million | +68.45% |
| 2005-03-31 | ₹210.75 Million | +9.68% |
| 2004-03-31 | ₹192.15 Million | +24.96% |
| 2003-03-31 | ₹153.76 Million | +9.68% |
| 2002-03-31 | ₹140.19 Million | -- |